177 related articles for article (PubMed ID: 35711030)
1. A systematic review of molecular alterations in invasive non-functioning pituitary adenoma.
Hosseinkhan N; Honardoost M; Emami Z; Cheraghi S; Hashemi-Madani N; Khamseh ME
Endocrine; 2022 Sep; 77(3):500-509. PubMed ID: 35711030
[TBL] [Abstract][Full Text] [Related]
2. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
Joshi H; Vastrad B; Vastrad C
J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
[TBL] [Abstract][Full Text] [Related]
3. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
Long Y; Lu M; Cheng T; Zhan X; Zhan X
Front Endocrinol (Lausanne); 2019; 10():835. PubMed ID: 31920959
[TBL] [Abstract][Full Text] [Related]
4. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
[TBL] [Abstract][Full Text] [Related]
5. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
6. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.
Zhan X; Wang X; Long Y; Desiderio DM
BMC Med Genomics; 2014 Dec; 7():69. PubMed ID: 25539738
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of invasive non-functional pituitary adenomas using exosomal biomarkers.
Ren Y; Wang Y; Bao X; Feng M; Xing B; Lian W; Yao Y; Wang R
Clin Chim Acta; 2022 Apr; 529():25-33. PubMed ID: 35085587
[TBL] [Abstract][Full Text] [Related]
10. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
11. In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness.
Zhou W; Song Y; Xu H; Zhou K; Zhang W; Chen J; Qin M; Yi H; Gustafsson JA; Yang H; Fan X
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1237-45. PubMed ID: 21632819
[TBL] [Abstract][Full Text] [Related]
12. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
14. Potential biomarkers of miRNA in non-functional pituitary adenomas.
Zhang Q; Wang Y; Zhou Y; Zhang Q; Xu C
World J Surg Oncol; 2021 Sep; 19(1):270. PubMed ID: 34503538
[TBL] [Abstract][Full Text] [Related]
15. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
16. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
Liu D; Li J; Li N; Lu M; Wen S; Zhan X
EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
Gu YH; Feng YG
J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
[TBL] [Abstract][Full Text] [Related]
18. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
19. Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas.
Kum SJ; Lee HW; Kim SG; Park H; Hwang I; Kim SP
J Pathol Transl Med; 2022 Jan; 56(1):22-31. PubMed ID: 34645111
[TBL] [Abstract][Full Text] [Related]
20. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
